Pathstone Family Office’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.3M Buy
7,629
+2,557
+50% +$509K 0.01% 611
2023
Q2
$1.15M Sell
5,072
-850
-14% -$174K 0.02% 437
2023
Q1
$1.35M Sell
5,922
-5,760
-49% -$1.42M 0.02% 369
2022
Q4
$2.68M Buy
11,682
+822
+8% +$219K 0.02% 420
2022
Q3
$2.87M Buy
10,860
+9,423
+656% +$2.4M 0.03% 332
2022
Q2
$300K Buy
+1,437
New +$321K 0.01% 795
2021
Q1
Sell
-101
Closed -$15K 683
2020
Q4
$15K Buy
101
+100
+10,000% +$11.9K ﹤0.01% 769
2020
Q3
$0 Hold
1
﹤0.01% 790
2020
Q2
$0 Hold
1
﹤0.01% 709
2020
Q1
$0 Buy
+1
New +$77 ﹤0.01% 756
2019
Q4
Sell
-1
Closed 420
2019
Q3
$0 Hold
1
﹤0.01% 611
2019
Q2
$0 Hold
1
﹤0.01% 635
2019
Q1
$0 Buy
+1
New +$82 ﹤0.01% 881
2014
Q4
Sell
-480
Closed -$28K 117
2014
Q3
$28K Buy
+480
New +$31.2K 0.09% 88

Other funds holding ALB

Pathstone Family Office's ALB Position: Q3 2023 in Review

Pathstone Family Office increased its Albemarle (ALB) stake by 50% in Q3 2023, buying an estimated $509K and bringing the position to 7,629 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #611.

Pathstone Family Office first reported a position in ALB in Q3 2014 and has held it in 14 quarters since. The position peaked at $2.87M in Q3 2022. 1,002 funds tracked by Wall St. Rank hold ALB as of Q3 2023.

  • Pathstone Family Office held 7,629 shares of Albemarle worth $1.3M as of Q3 2023.
  • Pathstone Family Office bought 2,557 Albemarle shares in Q3 2023, an estimated $509K.
  • Albemarle made up 0.01% of Pathstone Family Office's portfolio in Q3 2023, its #611 holding.
  • Pathstone Family Office first reported a position in Albemarle in Q3 2014 and has held it in 14 quarters since.
  • Pathstone Family Office's Albemarle position peaked at $2.87M in Q3 2022.
  • 1,002 funds tracked by Wall St. Rank held Albemarle as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.